Provided by Tiger Trade Technology Pte. Ltd.

Mangoceuticals, Inc.

0.3664
+0.00742.06%
Volume:578.79K
Turnover:216.26K
Market Cap:6.29M
PE:-0.23
High:0.3929
Open:0.3506
Low:0.3501
Close:0.3590
52wk High:2.75
52wk Low:0.1620
Shares:17.17M
Float Shares:11.69M
Volume Ratio:0.08
T/O Rate:4.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6207
EPS(LYR):-2.1664
ROE:-113.90%
ROA:-60.60%
PB:0.47
PE(LYR):-0.17

Loading ...

Mangoceuticals delays Q1 10-Q filing as auditor review takes longer

Reuters
·
May 16

Mangoceuticals Q4 EPS $(0.13) Up From $(1.01) YoY, Sales $94.360K Down From $105.247K YoY

Benzinga
·
Apr 02

Mangoceuticals FY25 net loss widens to $20.6 million; revenue falls to $0.5 million

Reuters
·
Apr 01

Mangoceuticals delays annual report filing as auditor needs more time to complete review

Reuters
·
Apr 01

Mangoceuticals Stock Doubles After Texas Lawsuit

Benzinga_recent_news
·
Mar 24

Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today?

TIPRANKS
·
Mar 23

Mangoceuticals Inc - Intends to Vigorously Pursue Its Claims and Defend Against Counterclaims Through Litigation Process

THOMSON REUTERS
·
Mar 18

Mangoceuticals Inc - Clarity Has Denied Co's Allegations and Has Asserted Counterclaims Related to Alleged Unpaid Invoices

THOMSON REUTERS
·
Mar 18

Mangoceuticals sues Clarity Ventures for more than USD 73 million

Reuters
·
Mar 18

Mangoceuticals announces patent filing for MGX-0024

TIPRANKS
·
Mar 07

Mangoceuticals Reports Zero Respiratory-Related Mortality in 29,000-Bird MGX-0024 Trials

Reuters
·
Mar 07

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

GlobeNewswire
·
Mar 07

Mangoceuticals Says MGX-0024 Cuts H5N1 Deaths and Eliminates Respiratory Mortality in Poultry Trials

Reuters
·
Feb 24

Mangoceuticals Inc - Mortality Reduced by up to 60% in Pre-Treatment Group

THOMSON REUTERS
·
Feb 24

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

GlobeNewswire
·
Feb 24

Mangoceuticals Shares Rise 81% on Strong Sales of Injectable Testosterone Therapy

THOMSON REUTERS
·
Feb 20

Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today

TIPRANKS
·
Feb 20

BUZZ-Mangoceuticals surges on strong sales of injectable testosterone therapy

Reuters
·
Feb 20

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

GlobeNewswire
·
Feb 20

Mangoceuticals files to sell 2.64M shares of common stock for holders

TIPRANKS
·
Jan 14